Comment on the article: “Neutrophillymphocyteratio as predictor of mortality inpatients with necrotizing fasciitis”
Main Article Content
Keywords
Fasciitis, Necrotizing, Mortality, Inflammation, Cross-Sectional Studies
Abstract
The neutrophil-lymphocyte ratio (NLR) is an index used to assess the balance between the state of inflammation and the immune response as it is associated with the levels of proinflammatory cytokines. It is widely used as a prognostic and mortality biomarker in various infectious and oncological diseases, such as necrotizing fasciitis, which is one of the main severe infections of soft tissues and skin, the relevance of which lies in timely diagnosis and effective treatment.
References
2. Wallace HA, Perera TB. Necrotizing Fasciitis. Treasure Island (FL): StatPearls Publishing; 2025.
3. Paul P, Vineed S, Chisthi MM, et al. Neutrophil to Lymphocyte Ratio: a useful predictor of amputation in patients with Necrotizing fasciitis: Diagnostic accuracy study. Research Square; 2022. DOI: 10.21203/rs.3.rs-1978771/v1.
4. Yildirim M, Gul S, Angin Y, et al. Lymphocyte-to-C-reactive protein ratio as a new biomarker for predicting mortality and morbidity in Fournier’s gangrene. Cir Cir. 2024;92(2):181-188. DOI: 10.24875/CIRU.22000529
5. Çelik M, Çiftçi MU, Çelik S, et al. Can The Systemic Immune-Inflammation Index (SII) and Charlson Comorbidity Index (CCI) be used to predict mortality in patients with necrotizing fasciitis?. International Orthopaedics. 2024;48:1707-1713. DOI: 10.1007/s00264-024-06190-9
6. Yildirim M, Dasiran F, Angin YS, et al. Lymphocyte-C-reactive protein ratio: a putative predictive factor for intestinal ischemia in strangulated abdominal wall hernias. Hernia. 2021;25:733-9. DOI: 10.1007/s10029-020-02174-x
7. Okugawa Y, Toiyama Y, Fujikawa H, et al. Prognostic potential of lymphocyte-C-reactive protein ratio in patients with rectal cancer receiving preoperative chemoradiotherapy. J Gastrointest Surg. 2021;25:492-502. DOI: 10.1007/s11605-019-04495-4
Article Sidebar
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors retain their copyright and grant the Revista Médica del IMSS the right of first publication. Articles are distributed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which allows sharing as long as the author and the original source are properly credited.